SAN FRANCISCO, May 02, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) have earned a consensus recommendation of “Buy” from the eight brokerages that are covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the stock […]
SAN FRANCISCO, April 08, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.
The Goldman Sachs Group began coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Free Report) in a research report released on Tuesday morning, MarketBeat reports. The firm issued a buy rating and a $24.00 target price on the stock. Other equities analysts have also recently issued reports about the stock. Citigroup started coverage on shares […]
Biotech ripe for 'cascade of dealmaking' - Here are the top companies to watch By Investing.com investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.